Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Gut
|
December 1, 1988
Altered gastrointestinal immune response in sarcoidosis
P A McCormick, C Feighery, C Dolan, et al.
Carcinogenesis
|
December 11, 1999
The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer
K J Sohn, M Puchyr, R N Salomon, et al.
Surgery
|
January 1, 1997
Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia
J A Rivera, C J Rall, F Graeme-Cook, et al.
Cancer Research
|
January 8, 2000
Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18
J A Morgan, Y Yin, A D Borowsky, et al.
Alimentary Pharmacology & Therapeutics
|
June 6, 2003
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial
W J Sandborn, B E Sands, D C Wolf, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Gut
|
December 1, 1988
Altered gastrointestinal immune response in sarcoidosis
P A McCormick, C Feighery, C Dolan, et al.
Carcinogenesis
|
December 11, 1999
The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer
K J Sohn, M Puchyr, R N Salomon, et al.
Surgery
|
January 1, 1997
Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia
J A Rivera, C J Rall, F Graeme-Cook, et al.
Cancer Research
|
January 8, 2000
Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18
J A Morgan, Y Yin, A D Borowsky, et al.
Alimentary Pharmacology & Therapeutics
|
June 6, 2003
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial
W J Sandborn, B E Sands, D C Wolf, et al.
Page
of 4